Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 464

1.

Phase II study of ketoconazole plus granulocyte-macrophage colony-stimulating factor for prostate cancer: effect of extent of disease on outcome.

Ryan CJ, Weinberg V, Rosenberg J, Fong L, Lin A, Kim J, Small EJ.

J Urol. 2007 Dec;178(6):2372-6; discussion 2377. Epub 2007 Oct 22.

PMID:
17936834
[PubMed - indexed for MEDLINE]
2.

Treatment of biochemical recurrence of prostate cancer with granulocyte-macrophage colony-stimulating factor secreting, allogeneic, cellular immunotherapy.

Urba WJ, Nemunaitis J, Marshall F, Smith DC, Hege KM, Ma J, Nguyen M, Small EJ.

J Urol. 2008 Nov;180(5):2011-7; discussion 2017-8. doi: 10.1016/j.juro.2008.07.048. Epub 2008 Sep 17.

PMID:
18801509
[PubMed - indexed for MEDLINE]
3.

Low dose ketoconazole with replacement doses of hydrocortisone in patients with progressive androgen independent prostate cancer.

Harris KA, Weinberg V, Bok RA, Kakefuda M, Small EJ.

J Urol. 2002 Aug;168(2):542-5.

PMID:
12131305
[PubMed - indexed for MEDLINE]
4.

A phase II trial of bortezomib and prednisone for castration resistant metastatic prostate cancer.

Morris MJ, Kelly WK, Slovin S, Ryan C, Eicher C, Heller G, Scher HI.

J Urol. 2007 Dec;178(6):2378-83; discussion 2383-4. Epub 2007 Oct 22.

PMID:
17936848
[PubMed - indexed for MEDLINE]
5.

Phase 2 study of granulocyte-macrophage colony-stimulating factor plus thalidomide in patients with hormone-naïve adenocarcinoma of the prostate.

Amato RJ, Hernandez-McClain J, Henary H.

Urol Oncol. 2009 Jan-Feb;27(1):8-13. doi: 10.1016/j.urolonc.2007.10.014. Epub 2008 Jan 14.

PMID:
18367123
[PubMed - indexed for MEDLINE]
6.

Safety and efficacy of the specific endothelin-A receptor antagonist ZD4054 in patients with hormone-resistant prostate cancer and bone metastases who were pain free or mildly symptomatic: a double-blind, placebo-controlled, randomised, phase 2 trial.

James ND, Caty A, Borre M, Zonnenberg BA, Beuzeboc P, Morris T, Phung D, Dawson NA.

Eur Urol. 2009 May;55(5):1112-23. doi: 10.1016/j.eururo.2008.11.002. Epub 2008 Nov 29.

PMID:
19042080
[PubMed - indexed for MEDLINE]
7.

Long-term outcome for men with androgen independent prostate cancer treated with ketoconazole and hydrocortisone.

Scholz M, Jennrich R, Strum S, Brosman S, Johnson H, Lam R.

J Urol. 2005 Jun;173(6):1947-52.

PMID:
15879788
[PubMed - indexed for MEDLINE]
8.

Response to low-dose ketoconazole and subsequent dose escalation to high-dose ketoconazole in patients with androgen-independent prostate cancer.

Nakabayashi M, Xie W, Regan MM, Jackman DM, Kantoff PW, Oh WK.

Cancer. 2006 Sep 1;107(5):975-81.

PMID:
16862573
[PubMed - indexed for MEDLINE]
Free Article
9.
10.

Therapy of advanced prostate cancer with granulocyte macrophage colony-stimulating factor.

Small EJ, Reese DM, Um B, Whisenant S, Dixon SC, Figg WD.

Clin Cancer Res. 1999 Jul;5(7):1738-44.

PMID:
10430077
[PubMed - indexed for MEDLINE]
Free Article
11.

A 1-year, open label, randomized phase II dose finding study of degarelix for the treatment of prostate cancer in North America.

Gittelman M, Pommerville PJ, Persson BE, Jensen JK, Olesen TK; Degarelix Study Group.

J Urol. 2008 Nov;180(5):1986-92. doi: 10.1016/j.juro.2008.07.033. Epub 2008 Sep 17.

PMID:
18801505
[PubMed - indexed for MEDLINE]
12.

An evaluation of high-doses ketoconazole with hydrocortisone substitution in hormone-refractory prostate cancer.

Argirovic Dj.

Acta Chir Iugosl. 2005;52(4):51-4.

PMID:
16673595
[PubMed - indexed for MEDLINE]
13.

Addition of estramustine to chemotherapy and survival of patients with castration-refractory prostate cancer: a meta-analysis of individual patient data.

Fizazi K, Le Maitre A, Hudes G, Berry WR, Kelly WK, Eymard JC, Logothetis CJ, Pignon JP, Michiels S; Meta-analysis of Estramustine in Prostate Cancer (MECaP) Trialists' Collaborative Group.

Lancet Oncol. 2007 Nov;8(11):994-1000. Epub 2007 Oct 17.

PMID:
17942366
[PubMed - indexed for MEDLINE]
14.

Phase II trial assessing granulocyte-macrophage-colony stimulating factor, ketoconazole plus mitoxantrone in metastatic castration-resistant prostate cancer progressing after docetaxel treatments.

Amato RJ, Saxena S, Stepankiw M.

Cancer Invest. 2013 Mar;31(3):177-82. doi: 10.3109/07357907.2013.764564. Epub 2013 Feb 12.

PMID:
23402284
[PubMed - indexed for MEDLINE]
15.

Phase II study of mitoxantrone and ketoconazole for hormone-refractory prostate cancer.

Eklund J, Kozloff M, Vlamakis J, Starr A, Mariott M, Gallot L, Jovanovic B, Schilder L, Robin E, Pins M, Bergan RC.

Cancer. 2006 Jun 1;106(11):2459-65.

PMID:
16615097
[PubMed - indexed for MEDLINE]
Free Article
16.

Testosterone recovery after prolonged androgen suppression in patients with prostate cancer.

Yoon FH, Gardner SL, Danjoux C, Morton G, Cheung P, Choo R.

J Urol. 2008 Oct;180(4):1438-43; discussion 1443-4. doi: 10.1016/j.juro.2008.06.029. Epub 2008 Aug 16.

PMID:
18710743
[PubMed - indexed for MEDLINE]
17.

Doxorubicin and dose-escalated cyclophosphamide with granulocyte colony-stimulating factor for the treatment of hormone-resistant prostate cancer.

Small EJ, Srinivas S, Egan B, McMillan A, Rearden TP.

J Clin Oncol. 1996 May;14(5):1617-25.

PMID:
8622080
[PubMed - indexed for MEDLINE]
18.

Granulocyte macrophage colony-stimulating factor--secreting allogeneic cellular immunotherapy for hormone-refractory prostate cancer.

Small EJ, Sacks N, Nemunaitis J, Urba WJ, Dula E, Centeno AS, Nelson WG, Ando D, Howard C, Borellini F, Nguyen M, Hege K, Simons JW.

Clin Cancer Res. 2007 Jul 1;13(13):3883-91.

PMID:
17606721
[PubMed - indexed for MEDLINE]
Free Article
19.

Efficacy of low-dose ketoconazole in hormone refractory prostate cancer patients at the National Cancer Centre and The Cancer Institute, Singapore.

Ngo LS, Yeo A, Wong AS, Tay MH.

Ann Acad Med Singapore. 2007 Oct;36(10):811-4.

PMID:
17987231
[PubMed - indexed for MEDLINE]
Free Article
20.

Clinical safety of a viral vector based prostate cancer vaccine strategy.

Arlen PM, Skarupa L, Pazdur M, Seetharam M, Tsang KY, Grosenbach DW, Feldman J, Poole DJ, Litzinger M, Steinberg SM, Jones E, Chen C, Marte J, Parnes H, Wright J, Dahut W, Schlom J, Gulley JL.

J Urol. 2007 Oct;178(4 Pt 1):1515-20. Epub 2007 Aug 16.

PMID:
17707059
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk